awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
Graphs
1
Q38777286-5E83EAC4-3571-489B-89E6-889532D5168A
Q38777286-5E83EAC4-3571-489B-89E6-889532D5168A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38777286-5E83EAC4-3571-489B-89E6-889532D5168A
Intervening to reduce the risk of future disability from multiple sclerosis: are we there yet?
P2860
Q38777286-5E83EAC4-3571-489B-89E6-889532D5168A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38777286-5E83EAC4-3571-489B-89E6-889532D5168A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7461b39747456da8b4d52b31909611b813e0a2a8
P2860
Alemtuzumab versus interferon β-1a in early relapsing-remitting multiple sclerosis: post-hoc and subset analyses of clinical efficacy outcomes.